TrialHematological oncology2019
Using circulating tumor DNA to monitor myelodysplastic syndromes status.
Pan Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it
TrialHematological oncology2019
Pan Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.